Posts Tagged ‘Marijuana Science’

White House Report Acknowledges Few Scientists Permitted To Assess Cannabis Use In Humans

medical marijuana blog

Only fourteen researchers in the United States are legally permitted to conduct research assessing the effect of inhaled cannabis in human subjects, according to data included in the White House’s 2011 National Drug Control Strategy, released last week.

In a section of the report entitled ‘Medical Marijuana,’ the administration states, “In the United States, the Drug Enforcement Administration (DEA) has approved 109 researchers to perform bona fide research with marijuana, marijuana extracts, and marijuana derivatives such as cannabidiol and cannabinol.” However, it later clarifies that of these 109 scientists, only fourteen “are approved to conduct research with smoked marijuana on human subjects.”

Among those scientists licensed to work with either cannabis or its constituents — primarily in animal models — most are involved in research to assess the drug’s “abuse potential, physical/psychological effects, [and] adverse effects,” the report stated.

In 2010, a spokesperson for the US National Institute on Drug Abuse (NIDA) — the federal agency that must approve any US clinical trial involving marijuana – told the New York Times: “[O]ur focus is primarily on the negative consequences of marijuana use. We generally do not fund research focused on the potential beneficial medical effects of marijuana.”

NormlEarlier this month, DEA Administrator Michele Leonhart denied a nine-year-old petition seeking to initiate hearings regarding the federal classification of cannabis as a schedule I substance, stating in part, “[T]here are no adequate and well-controlled studies proving efficacy.”

Commenting on the report, NORML Deputy Director Paul Armentano said: “Only in an environment of absolute criminal prohibition would this or any administration purport to the public that it is acceptable to allow no more than fourteen researchers to clinically study a substance consumed by tens of millions of Americans for therapeutic or recreational purposes. This acknowledgement illustrates once again the administration’s supposed commitment to ‘scientific integrity’ does not apply to cannabis.”

For more information, please contact Allen St. Pierre, NORML Executive Director, at (202) 483-5500 or Paul Armentano, NORML Deputy Director at: paul@norml.org.

Documentary Planned for Cancer Patient Cured by MMJ

Medical Marijuana

Cannabis Science Inc. (nasd otcbb:CBIS) a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce that it has been contacted by Lynnice Wedewer, Ph.D. who is a 34 year multiple cancer patient survivor who has been cured of 7 of her 8 cancers in a major part because of medical cannabis. Dr. Wedewer wishes to share her story through Cannabis Science and help our case and education towards general acceptance of medical cannabis as a natural and viable treatment for cancer.

In 1979, Iowa passed a medical marijuana law which impacted five children suffering from cancer and who were placed into a cancer treatment program using medical cannabis under the supervision of the University of Iowa. Dr. Wedewer was one of those children and only 1 1/2 years ago did the law in Iowa finally change to allow these patients to finally speak out about their treatment and success stories in battling cancer with medical cannabis.

The Company is excited to feature Dr. Lynnice Wedewer’s cancer success story and testimonial in its upcoming documentary, along with other cancer survivors who were cured through the use of medical cannabis.

Dr. Wedewer runs a website http://www.lynnicewedewer.com where she provides her testimony, speeches, educational material, marijuana facts, interviews and documentaries, and other informational links regarding marijuana.

Purple Nug

Dr. Robert Melamede, Ph. D., Cannabis Science Inc., President & CEO said, “These are exciting times to be part of a burgeoning medical marijuana movement and shedding light on patients who are telling their stories and opening up medical files to demonstrate the cancer curing power of medical cannabis. We are enthusiastic and hopefully that Dr. Lynnice Wedewer’s testimonial and cancer success along with other patient success stories, including profound medical evidence, will help to educate and finally open up the eyes of federal regulators to decriminalize medical cannabis; so more people’s lives can be saved by this natural herbal remedy and stop killing people with man-made pharmaceuticals.”

About Cannabis Science, Inc.

Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.

Follow

Get every new post delivered to your Inbox.

Join 130 other followers

%d bloggers like this: